Contraceptive prevalence, any modern method in France
France: Contraceptive prevalence, any modern method was 72.7% in 2010. ▲ Rising
Contraceptive prevalence, any modern method in France, 1978–2010
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
In 2010, contraceptive prevalence, any modern method in France stood at 72.7%.
That represents a change of up 2.4% on the previous year and down 2.8% over ten years.
Over the whole period, contraceptive prevalence, any modern method in France peaked at 74.8% in 2005 and was at its lowest, 47.6%, in 1978.
France ranks 8th of 113 countries on this measure, in the top 10%.
Contraceptive prevalence, any modern method in France, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1978 | 47.6% | — |
| 1988 | 66.6% | +39.9% |
| 1994 | 69.3% | +4.1% |
| 2005 | 74.8% | +7.9% |
| 2008 | 71.0% | -5.1% |
| 2010 | 72.7% | +2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1970s | 47.6% | 47.6% | 47.6% | 1 |
| 1980s | 66.6% | 66.6% | 66.6% | 1 |
| 1990s | 69.3% | 69.3% | 69.3% | 1 |
| 2000s | 72.9% | 71.0% | 74.8% | 2 |
| 2010s | 72.7% | 72.7% | 72.7% | 1 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in France?
- Contraceptive prevalence, any modern method in France was 72.7% in 2010, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in France?
- The highest recorded value was 74.8% in 2005.
- What is the lowest contraceptive prevalence, any modern method recorded in France?
- The lowest recorded value was 47.6% in 1978.
- How does France rank for contraceptive prevalence, any modern method?
- France ranks 8th out of 113 countries with data for 2010.
- Is contraceptive prevalence, any modern method rising or falling in France?
- Over the last ten years it is down 2.8%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.